Seeking Alpha

Maxim weighs in on Cytori Therapeutics' (CYTX +18%) new government contract, calling it a...

Maxim weighs in on Cytori Therapeutics' (CYTX +18%) new government contract, calling it a significant strategic positive. The firm reiterates its Buy rating on the stock with a $10 price target.
Comments (1)
  • I like CYTX, but I would like to know their plans for cash flow. This seems to be a good time for them to offer more equity. I'd prefer to buy after the dilution rather than before.
    1 Oct 2012, 04:18 AM Reply Like
DJIA (DIA) S&P 500 (SPY)